Form 8-K
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 27, 2009

BioMed Realty Trust, Inc.
(Exact name of registrant as specified in its charter)

         
Maryland   1-32261   20-1142292
(State or other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)
     
17190 Bernardo Center Drive
San Diego, California
  92128
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (858) 485-9840

 
 
(Former name or former address if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 

1


 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

At the annual meeting of stockholders of BioMed Realty Trust, Inc. held on May 27, 2009, BioMed’s stockholders approved the amendment and restatement of the 2004 Incentive Award Plan of BioMed Realty Trust, Inc. and BioMed Realty, L.P. (the “Incentive Award Plan”), which increased the number of shares of common stock available for issuance under the Incentive Award Plan by 2,840,000 shares, extended the term of the Incentive Award Plan to 2019 and made certain other changes which the board of directors of BioMed believes will more closely align the terms of the Incentive Award Plan with best practices and stockholder interests.

The foregoing description of the Incentive Award Plan does not purport to be complete and is qualified in its entirety by reference to the complete text of the Incentive Award Plan, which is filed as Exhibit 10.1 to this report and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) The following exhibits are filed herewith:

     
Exhibit
   
Number
  Description of Exhibit
 
   
10.1
  2004 Incentive Award Plan of BioMed Realty Trust, Inc. and BioMed Realty, L.P. (as Amended and Restated Effective May 27, 2009).

 

2


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 1, 2009

BIOMED REALTY TRUST, INC.

By: /s/ Kent Griffin                        
Name: Kent Griffin
Title: President, Chief Operating Officer and Chief Financial Officer

 

3


 

EXHIBIT INDEX

     
Exhibit
   
Number
  Description of Exhibit
 
   
10.1
  2004 Incentive Award Plan of BioMed Realty Trust, Inc. and BioMed Realty, L.P. (as Amended and Restated Effective May 27, 2009).

 

4